CCO Mikkel Raahauge Nielsen buys shares in the Company
CS MEDICA A/S (“CS MEDICA” or the “Company”) announces today that the CCO – Global Sales, of the Company, Mikkel Raahauge Nielsen, has acquired 20 458 shares in CS MEDICA through several transactions at an average price of 8,95, amounting to a total value of 183 161 DKK.
The CCO – Head of Global Sales of CS MEDICA, Mikkel Raahauge Nielsen, has purchased 20 458 shares in the open market at an average price of DKK 8,95 per share, corresponding to a total purchase of 183 161 DKK. The transactions have been disclosed to the Danish financial supervisory register. Following the transaction, Mikkel owns 20 458 CS MEDICA shares.
Mikkel Raahauge Nielsen is part of the Executive Management team and got a strong belief in the future of CS Medica and the team.
For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.